Gilead Sciences, Inc. Insider Trades

Insider Trading History

Track insider trading activity for Gilead Sciences, Inc.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Assembly Biosciences
Assembly Biosciences ASMB
10% owner
Holding Value $133M 4,977,089 shares
Last Trade
May 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5M 471,698 shares
$26.50
$26.80
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $359M 40,384,266 shares
Last Trade
Feb 13, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.4M 3,739,000 shares
$8.12
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $326M 36,645,266 shares
Last Trade
Nov 26, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$140M 13,335,000 shares
$10.50
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $0 0 shares
Last Trade
Nov 26, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$140M 13,335,000 shares
$10.50
$8.90
Assembly Biosciences
Assembly Biosciences ASMB
10% owner
Holding Value $121M 4,505,391 shares
Last Trade
Aug 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.8M 1,147,960 shares
$21.60
$26.80
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $207M 23,310,266 shares
Last Trade
Jun 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.05M 13,335,000 shares
$0.68
$8.90
Arcus Biosciences
Arcus Biosciences RCUS
10% owner
Holding Value $886M 31,424,760 shares
Last Trade
Feb 18, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15M 1,363,636 shares
$11.00
$28.18
Assembly Biosciences
Assembly Biosciences ASMB
10% owner
Holding Value $59.2M 2,209,471 shares
Last Trade
Dec 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.4M 940,499 shares
$14.28
$26.80
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $88.8M 9,975,266 shares
Last Trade
Dec 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.63M 1,759,978 shares
$0.93
$8.90
Assembly Biosciences
Assembly Biosciences ASMB
10% owner
Holding Value $34M 1,268,972 shares
Last Trade
Jun 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.72M 179,500 shares
$15.16
$26.80
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $65.4M 7,345,473 shares
Last Trade
Apr 02, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$718k 485,250 shares
$1.48
$8.90
Kyverna Therapeutics
Kyverna Therapeutics KYTX
10% owner
Holding Value $27.1M 3,216,119 shares
Last Trade
Feb 12, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$96.3M 3,216,119 shares
$29.93
$8.43
Kyverna Therapeutics
Kyverna Therapeutics KYTX
10% owner
Holding Value $34.8M 4,126,119 shares
Last Trade
Feb 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.2M 910,000 shares
$29.93
$8.43
Arcus Biosciences
Arcus Biosciences RCUS
10% owner
Holding Value $847M 30,061,124 shares
Last Trade
Jan 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$233M 15,238,095 shares
$15.30
$28.18
Gilead Sciences
Gilead Sciences GILD
10% owner
Holding Value $1.85B 14,823,029 shares
Last Trade
Jun 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$76.9M 1,010,000 shares
$76.18
$125.05
Arcus Biosciences
Arcus Biosciences RCUS
10% owner
Holding Value $418M 14,823,029 shares
Last Trade
Jun 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.5M 1,010,000 shares
$19.26
$28.18
Gilead Sciences
Gilead Sciences GILD
10% owner
Holding Value $2.08B 16,635,286 shares
Last Trade
Jun 27, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$223M 2,930,870 shares
$76.01
$125.05
AlloVir
AlloVir ALVR
10% owner
Holding Value $163M 16,635,286 shares
Last Trade
Jun 27, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.41M 2,930,870 shares
$3.21
$9.81
Gilead Sciences
Gilead Sciences GILD
10% owner
Holding Value $1.74B 13,913,029 shares
Last Trade
Jan 31, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$371M 5,650,000 shares
$65.60
$125.05
Arcus Biosciences
Arcus Biosciences RCUS
10% owner
Holding Value $392M 13,913,029 shares
Last Trade
Jan 31, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$196M 5,650,000 shares
$34.73
$28.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up